International Psoriasis Council

Advancing Knowledge. Improving Care.

Lisa Zhenying Zhang Headshot

Lisa

Zhenying Zhang

,

MD, PhD

Chief Physician and Director of Dermatology
University of Hong Kong-Shenzhen Hospital
Shenzhen
,
China
Councilor Since: April 11, 2025
IPC Councilor
Dr. Lisa Zhenying Zhang is a professor of dermatology, serving as the Head of the Dermatology Department and Consultant Physician at The University of Hong Kong-Shenzhen Hospital, as well as a Doctoral Supervisor. She was a Visiting Scholar at the University of Miami, United States, and has been honored with the titles of Guangdong Outstanding Young Medical Talent and Shenzhen High-Level Professional. Dr. Zhenying Zhang mainly engages in basic scientific research on psoriasis recurrence mechanisms and clinical research on precision treatment. As Principal Investigator (PI), she has led over twenty GCP and IIT clinical studies, two National Natural Science Foundation projects, four Shenzhen Science and Technology Innovation Commission projects, and one SMART project. Dr. Zhenying Zhang has been awarded three provincial/municipal Science and Technology Progress Awards and has published over forty papers in international journals, including the New England Journal of Medicine (NEJM), Medical Journal of Australia (MJA), British Journal of Dermatology (BJD), American Journal of Clinical Dermatology (AJCD), and Journal of the European Academy of Dermatology and Venereology (JEADV).
Last Updated:
05/07/2025

Areas of Interest

Precision Therapy for Special Subtypes of Psoriasis

Languages Spoken

English, Mandarin

What's New

Videos Now Available from the IPC Symposium at SID Chicago

Did you miss the IPC symposium at the 83rd Society for Investigative Dermatology (SID) Annual Meeting? Select session videos are now available. The Arc of Disease Control in Psoriasis: Early Interception – Deep Pathway Blockade – Treatment Failure covered early intervention strategies, treatment selection, immune pathway targeting, PsA prevention, clinical escape, and real-world cases that inform long-term psoriasis care.

WATCH NOW

Wednesday, June 17, 2026

Take Ten: Mio Nakamura – Psoriasis and Mental Health

Depression affects approximately 20% of patients with psoriasis, five times the rate seen in the general population. IPC Jr. Councilor Mio Nakamura, MD, MS, FAAD, walks through the bidirectional relationship between psoriasis and depression, the shared inflammatory pathways driving both conditions, and practical guidance on screening and incorporating multidisciplinary mental health support into psoriasis management.

WATCH NOW

Thursday, June 11, 2026